ODYSSION

Welcome to the Brand page for “ODYSSION”, which is offered here for Pharmaceutical and veterinary preparations and substances; biopharmaceutical preparations and substances; chemical, biochemical and biological preparations for medical and veterinary purposes; cells, cell lines, and cell cultures for use in the production of proteins for therapeutic use; proteins for use as medical therapeutic reagents; antibodies; vaccines;reagents for use in medical research and biological analysis; proteins for use in the manufacture of pharmaceuticals and reagents; proteins for use in medical research;scientific and technological services and research and design relating thereto; laboratory research services; medical and pharmacological research services; analysis and measurement of substances; analysis and measurement of molecules and characteristics; bioanalysis services; scientific imaging services; biochemical analysis; scientific research and development services; medical research and development services; pharmaceutical research and development services; biological research and analysis; biomedical research services; biotechnological research; biotechnology testing; chemical research and analysis; research and development of new products for others in the biotechnical, biomedical and pharmaceutical fields; research and development for the pharmaceutical industry; research and development of vaccines and medicines; research and development services in the field of antibodies; research and development services in the field of antibody technology; research and development services in the field of immunology; medical laboratory services; research of pharmaceuticals; research relating to molecular sciences; research relating to pharmaceuticals; biopharmaceutical research, development and testing services; drug discovery services; drug development services; pharmaceutical drug development services; conducting early evaluations in the field of new pharmaceuticals; research and development of molecules for therapeutic purposes; consultancy, advisory and/or information services in relation to all the aforesaid services;.

Its status is currently believed to be active. Its class is unavailable. “ODYSSION” is believed to be currently owned by “OMASS Therapeutics Limited”.